Samsung BioLogics, Bristol enter manufacturing deal for melanoma drug

07/31/2013 | PharmaTimes (U.K.)

Samsung BioLogics signed a 10-year deal to manufacture Bristol-Myers Squibb's melanoma drug Yervoy, or ipilimumab, at its facility in Songdo Incheon, South Korea. Samsung is beginning trial production, and commercial production will follow the securing of regulatory OKs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations